Physician profile
Rohit Sharma
NPI 1427059344
$4,507.21
in general payments reported to CMS, 2019-2025
18 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.15 · 2020: $47.16 · 2021: $134 · 2022: $240 · 2023: $1,714 · 2024: $1,838 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,065 · Food and Beverage: $1,992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,065.37 |
| Food and Beverage | $1,992.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,656.31 | 2021-2024 | Ellipsys Vascular Access System |
| Fresenius USA Marketing, INC. | $549.49 | 2021-2025 | Velphoro, Velphoro, Korsuva |
| Nxstage Medical, INC. | $225.19 | 2021-2025 | Nxstage System One, Liberty Select Cycler |
| Mallinckrodt Hospital Products INC. | $197.32 | 2023-2025 | Acthar |
| Inari Medical, INC. | $178.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $170.38 | 2020-2025 | Krystexxa |
| Ardelyx, INC. | $100.87 | 2024-2025 | Ibsrela |
| Mozarc Medical US LLC | $100.73 | 2024 | Chameleon |
| Boston Scientific Corporation | $49.18 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $45.70 | 2024 | Farxiga |
| Laminate Medical Technologies INC. | $42.50 | 2025 | Vasq |
| W. L. Gore & Associates, INC. | $42.40 | 2019-2025 | Gore Viabahn Endoprosthesis |
| Venturemed Group, INC. | $38.07 | 2025 | Flex Vessel Prep System |
| Bard Peripheral Vascular, INC. | $35.27 | 2019-2024 | Fluency Endovascular Stent Graft |
| Horizon Therapeutics Plc | $21.15 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $19.21 | 2022 | |
| Aurinia Pharma U.S., INC. | $18.02 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.